AVDL vs CNC · rev $169.1M vs P/E 8.4, rev $103.52B
Avadel Pharmaceuticals PLC (AVDL) versus Centene Corp (CNC) — a side-by-side from cached financials, not a winner call.
Avadel Pharmaceuticals PLC (AVDL) is a drug manufacturers - specialty & generic company listed on US.
Centene Corp (CNC) is a healthcare plans company listed on US.
Latest reported AVDL revenue for 2024-12-31 was $169.1M. Net income was -$48.8M. Revenue was up 504.8% from 2023-12-31 to 2024-12-31. AVDL currently screens at market cap $968.5M.
Latest reported CNC revenue for 2026-06-30 was $103.52B. Net income was $2.63B. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
AVDL currently screens at market cap $968.5M. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
Not investment advice. Open the AVDL and CNC stock pages for the full models.
Not investment advice.